IFNA1 and cancer: In addition to tumor production of immunosuppressive cytokines, regulatory T cells—which are expanded in cancer patients [52,53]—produce cytokines such as IL-10 and TGF-β1 and may contribute to the inhibition of IFN signaling in lymphocytes in the cancer state.